Creo Medical Group 주식 주식분석 | 주식가격 | 뉴스 | CREO.L | GB00BZ1BLL44 | A2DH40

날짜	Creo Medical Group 주식 가격
	0.14 undefined
	0.14 undefined
	0.15 undefined
	0.14 undefined
	0.15 undefined
	0.15 undefined
	0.15 undefined
	0.15 undefined
	0.16 undefined
	0.16 undefined
	0.16 undefined
	0.17 undefined
	0.17 undefined
	0.19 undefined
	0.19 undefined
	0.20 undefined
	0.20 undefined
	0.19 undefined
	0.19 undefined
	0.19 undefined
	0.18 undefined

날짜	Creo Medical Group 매출	Creo Medical Group EBIT	Creo Medical Group 이익
2030e	63.8 백만 undefined	0 undefined	0 undefined
2029e	47.96 백만 undefined	9.29 백만 undefined	0 undefined
2028e	33.63 백만 undefined	-323,928.6 undefined	0 undefined
2027e	20.47 백만 undefined	-8.02 백만 undefined	-5.08 백만 undefined
2026e	22.22 백만 undefined	-13.33 백만 undefined	-10.69 백만 undefined
2025e	16.28 백만 undefined	-19.04 백만 undefined	-12.28 백만 undefined
2024e	31.55 백만 undefined	-24.34 백만 undefined	-21.69 백만 undefined
2023	30.8 백만 undefined	-24.8 백만 undefined	-21.7 백만 undefined
2022	27.17 백만 undefined	-30.76 백만 undefined	-26.94 백만 undefined
2021	25.16 백만 undefined	-29.91 백만 undefined	-24.6 백만 undefined
2020	9.43 백만 undefined	-23.48 백만 undefined	-20.32 백만 undefined
2019	13,500 undefined	-18.88 백만 undefined	-15.91 백만 undefined
2018	0 undefined	-17.66 백만 undefined	-14.81 백만 undefined
2017	0 undefined	-8.9 백만 undefined	-7.77 백만 undefined
2016	0 undefined	-1.87 백만 undefined	-1.61 백만 undefined
2015	0 undefined	-3.8 백만 undefined	-3.33 백만 undefined
2014	0 undefined	-2.88 백만 undefined	-2.38 백만 undefined
2013	0 undefined	-1.95 백만 undefined	-1.7 백만 undefined

	매출	EBIT	이익
2013	0 GBP	-1.95 백만 GBP	-1.7 백만 GBP
2014	0 GBP	-2.88 백만 GBP	-2.38 백만 GBP
2015	0 GBP	-3.8 백만 GBP	-3.33 백만 GBP
2016	0 GBP	-1.87 백만 GBP	-1.61 백만 GBP
2017	0 GBP	-8.9 백만 GBP	-7.77 백만 GBP
2018	0 GBP	-17.66 백만 GBP	-14.81 백만 GBP
2019	13,500 GBP	-18.88 백만 GBP	-15.91 백만 GBP
2020	9.43 백만 GBP	-23.48 백만 GBP	-20.32 백만 GBP
2021	25.16 백만 GBP	-29.91 백만 GBP	-24.6 백만 GBP
2022	27.17 백만 GBP	-30.76 백만 GBP	-26.94 백만 GBP
2023	30.8 백만 GBP	-24.8 백만 GBP	-21.7 백만 GBP
2024e	31.55 백만 GBP	-24.34 백만 GBP	-21.69 백만 GBP
2025e	16.28 백만 GBP	-19.04 백만 GBP	-12.28 백만 GBP
2026e	22.22 백만 GBP	-13.33 백만 GBP	-10.69 백만 GBP
2027e	20.47 백만 GBP	-8.02 백만 GBP	-5.08 백만 GBP
2028e	33.63 백만 GBP	-323,928.6 GBP	0 GBP
2029e	47.96 백만 GBP	9.29 백만 GBP	0 GBP
2030e	63.8 백만 GBP	0 GBP	0 GBP

2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e	2029e	2030e
0	0	0	0	0	0	0	9	25	27	30	31	16	22	20	33	47	63
-	-	-	-	-	-	-	-	177.78	8.00	11.11	3.33	-48.39	37.50	-9.09	65.00	42.42	34.04
-	-	-	-	-	-	-	44.44	44.00	48.15	50.00	48.39	93.75	68.18	75.00	45.45	31.91	23.81
0	0	0	0	0	0	0	4	11	13	15	0	0	0	0	0	0	0
-1	-2	-3	-1	-7	-14	-15	-20	-24	-26	-21	-21	-12	-10	-5	0	0	0
-	100.00	50.00	-66.67	600.00	100.00	7.14	33.33	20.00	8.33	-19.23	-	-42.86	-16.67	-50.00	-	-	-
80.74	80.74	80.82	83.74	83.74	93.78	125.84	161.58	170.38	187.89	313	0	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2013	2014	2015	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.89	0.31	0.31	2.57	0.82	13.69	44.59	81.05	45.09	43.53	13.1	18.5
0.3	0.11	0.11	0.41	0.26	0.06	0.16	0.06	4.27	3.94	5.25	7.8
0.3	0.51	0.51	0.56	0.96	1.63	3.15	4.02	3.06	4.82	4.93	2.8
0	0	0	0	0	0.09	0.3	0.73	6.81	8.5	9.33	8.1
0	0	0	0	0.09	0.3	0.31	0.24	0.23	0.37	1.09	0.7
1.49	0.92	0.92	3.54	2.15	15.77	48.51	86.09	59.47	61.17	33.69	37.9
0.14	0.13	0.13	0.2	0.24	0.33	0.91	1.3	3.38	8.6	10.18	9.1
0	0	0	0	0	0	0	0	0.5	1.73	2.12	2.1
0	0	0	0	13.1	14.9	8.4	8.4	0	0	0	0
0	0	0	0	0.01	0.01	0.31	0.87	10.27	8.69	8.08	7.1
0	0	0	0	0	0	0	0	18.26	18.56	19.56	19.1
0	0	0	0	0.01	0	0.01	0	0.59	1.85	1.7	1.3
0.14	0.13	0.13	0.2	0.27	0.35	1.23	2.17	32.99	39.44	41.65	38.7
1.63	1.04	1.04	3.74	2.42	16.12	49.75	88.26	92.46	100.61	75.34	76.6

20	17.9	17.89	18.3	1.4	80.7	120.5	150.4	158	181	182	400
6.19	7.94	7.94	13.46	0	19.81	65.84	115.11	115.26	149.45	149.52	180.9
-4.83	-7.21	-7.21	-10.26	1.63	-5.24	-18.24	-32.6	-52.19	-74.22	-99.76	-120.3
0	0	0	0	0	0	0	0	-0.43	-2.09	-0.54	-1.2
0	0	0	0	0	0	0	0	0	0	0	0
1.38	0.75	0.75	3.22	1.63	14.65	47.71	82.66	62.81	73.32	49.4	59.8
0.15	0.17	0.17	0.24	0.33	0.52	0.74	0.92	2.46	3.54	4.28	2.5
0.1	0.12	0.12	0.25	0.43	0.66	0.76	3.92	4.03	5.18	3.6	2.4
0	0	0	0.01	0.01	0.27	0.1	0.04	5.72	5.63	3.99	1.9
0	0	0	0	0	0	0	0	0	0	2.25	2
0	0	0	0.01	0.01	0.01	0.04	0.17	5.81	5.38	3.37	1.1
0.25	0.3	0.3	0.51	0.77	1.47	1.64	5.06	18.03	19.74	17.48	9.9
0	0	0	0.02	0.02	0	0.39	0.54	6.54	5.18	6.07	5.2
0	0	0	0	0	0	0	0	2	1.79	2	1.4
0	0	0	0	0	0	0	0	3.09	0.59	0.38	0.3
0	0	0	0.02	0.02	0	0.39	0.54	11.63	7.55	8.45	6.9
0.25	0.3	0.3	0.53	0.79	1.47	2.03	5.6	29.66	27.29	25.93	16.8
1.63	1.04	1.04	3.75	2.42	16.12	49.75	88.26	92.46	100.61	75.34	76.6

2013	2014	2015	2015	null	2016	2017	2018	2019	2020	2021	2022
-1	-2	-2	-3	-3	-1	-7	-14	-15	-20	-24	-26
0	0	0	0	0	0	0	0	0	1	2	3
0	0	0	0	0	0	0	0	0	0	-1	0
0	0	0	0	0	0	1	1	4	4	-1	1
0	0	0	0	0	0	0	-1	-1	-2	-2	-2
0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	-1	-2	-2	-3	-4
-1	-2	-2	-3	-3	-1	-6	-14	-11	-16	-26	-25
0	0	0	0	0	0	0	-1	-1	0	-6	-3
0	0	0	0	0	0	0	-1	0	-20	-7	-5
0	0	0	0	0	0	0	0	0	-20	-1	-2
0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	1,000	-2,000	0
2	1	1	5	5	0	20	46	49	0	34	0
2	1	1	5	5	0	20	46	49	1	31	0
-	-	-	-	-	-	-	-	-	-	-2.00	-
0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	2	2	-1	12	30	36	-35	-1	-30
-1.4	-2.34	-2.34	-3.27	0	-1.73	-7.14	-15.69	-12.97	-16.86	-32.13	-28.33
0	0	0	0	0	0	0	0	0	0	0	0

Creo Medical Group 브루토마진	Creo Medical Group 이익 마진	Creo Medical Group EBIT-마진	Creo Medical Group 이익 마진
2030e	49.68 %	0 %	0 %
2029e	49.68 %	19.36 %	0 %
2028e	49.68 %	-0.96 %	0 %
2027e	49.68 %	-39.2 %	-24.83 %
2026e	49.68 %	-60.01 %	-48.1 %
2025e	49.68 %	-116.95 %	-75.41 %
2024e	49.68 %	-77.16 %	-68.76 %
2023	49.68 %	-80.52 %	-70.45 %
2022	48.3 %	-113.2 %	-99.14 %
2021	46.04 %	-118.86 %	-97.75 %
2020	42.79 %	-249.07 %	-215.46 %
2019	37.04 %	-139,817.77 %	-117,860.73 %
2018	49.68 %	0 %	0 %
2017	49.68 %	0 %	0 %
2016	49.68 %	0 %	0 %
2015	49.68 %	0 %	0 %
2014	49.68 %	0 %	0 %
2013	49.68 %	0 %	0 %

	브루토마진	EBIT-마진	이익 마진
2013	49.68 %	0 %	0 %
2014	49.68 %	0 %	0 %
2015	49.68 %	0 %	0 %
2016	49.68 %	0 %	0 %
2017	49.68 %	0 %	0 %
2018	49.68 %	0 %	0 %
2019	37.04 %	-139,817.77 %	-117,860.73 %
2020	42.79 %	-249.07 %	-215.46 %
2021	46.04 %	-118.86 %	-97.75 %
2022	48.3 %	-113.2 %	-99.14 %
2023	49.68 %	-80.52 %	-70.45 %
2024e	49.68 %	-77.16 %	-68.76 %
2025e	49.68 %	-116.95 %	-75.41 %
2026e	49.68 %	-60.01 %	-48.1 %
2027e	49.68 %	-39.2 %	-24.83 %
2028e	49.68 %	-0.96 %	0 %
2029e	49.68 %	19.36 %	0 %
2030e	49.68 %	0 %	0 %

날짜	Creo Medical Group 주당 매출	Creo Medical Group EBIT 당 주식	Creo Medical Group 주당 이익
2030e	0.15 undefined	0 undefined	0 undefined
2029e	0.12 undefined	0 undefined	0 undefined
2028e	0.08 undefined	0 undefined	0 undefined
2027e	0.05 undefined	0 undefined	-0.01 undefined
2026e	0.05 undefined	0 undefined	-0.03 undefined
2025e	0.04 undefined	0 undefined	-0.03 undefined
2024e	0.08 undefined	0 undefined	-0.05 undefined
2023	0.1 undefined	-0.08 undefined	-0.07 undefined
2022	0.14 undefined	-0.16 undefined	-0.14 undefined
2021	0.15 undefined	-0.18 undefined	-0.14 undefined
2020	0.06 undefined	-0.15 undefined	-0.13 undefined
2019	0 undefined	-0.15 undefined	-0.13 undefined
2018	0 undefined	-0.19 undefined	-0.16 undefined
2017	0 undefined	-0.11 undefined	-0.09 undefined
2016	0 undefined	-0.02 undefined	-0.02 undefined
2015	0 undefined	-0.05 undefined	-0.04 undefined
2014	0 undefined	-0.04 undefined	-0.03 undefined
2013	0 undefined	-0.02 undefined	-0.02 undefined

	주당 매출	EBIT 당 주식	주당 이익
2013	0 GBP	-0.02 GBP	-0.02 GBP
2014	0 GBP	-0.04 GBP	-0.03 GBP
2015	0 GBP	-0.05 GBP	-0.04 GBP
2016	0 GBP	-0.02 GBP	-0.02 GBP
2017	0 GBP	-0.11 GBP	-0.09 GBP
2018	0 GBP	-0.19 GBP	-0.16 GBP
2019	0 GBP	-0.15 GBP	-0.13 GBP
2020	0.06 GBP	-0.15 GBP	-0.13 GBP
2021	0.15 GBP	-0.18 GBP	-0.14 GBP
2022	0.14 GBP	-0.16 GBP	-0.14 GBP
2023	0.1 GBP	-0.08 GBP	-0.07 GBP
2024e	0.08 GBP	0 GBP	-0.05 GBP
2025e	0.04 GBP	0 GBP	-0.03 GBP
2026e	0.05 GBP	0 GBP	-0.03 GBP
2027e	0.05 GBP	0 GBP	-0.01 GBP
2028e	0.08 GBP	0 GBP	0 GBP
2029e	0.12 GBP	0 GBP	0 GBP
2030e	0.15 GBP	0 GBP	0 GBP

	주식 수량
2013	80.74 백만 Aktien
2014	80.74 백만 Aktien
2015	80.82 백만 Aktien
2016	83.74 백만 Aktien
2017	83.74 백만 Aktien
2018	93.78 백만 Aktien
2019	125.84 백만 Aktien
2020	161.58 백만 Aktien
2021	170.38 백만 Aktien
2022	187.89 백만 Aktien
2023	313 백만 Aktien
2024e	313 백만 Aktien
2025e	313 백만 Aktien
2026e	313 백만 Aktien
2027e	313 백만 Aktien
2028e	313 백만 Aktien
2029e	313 백만 Aktien
2030e	313 백만 Aktien

%-지분	이름	주식	변경
8.73137 %	Canaccord Genuity Wealth Management	36,014,293	-3,288,771
8.14913 %	M&G Investment Management Ltd.	33,612,732	24,184,232
5.67843 %	Baillie Gifford & Co.	23,421,836	10,884,395
4.12125 %	Amati Global Investors Limited	16,998,915	-455,067
3.89894 %	AXA Investment Managers UK Ltd.	16,081,958	8,088,997
3.48552 %	Development Bank of Wales Plc	14,376,727	-5,400,000
3.48527 %	River Global Investors LLP	14,375,697	13,026,717
3.04300 %	BlackRock Investment Management (UK) Ltd.	12,551,455	4,250,000
3.01208 %	SVM Asset Management Limited	12,423,907	1,800,000
2.42442 %	Creo Medical Group Employee Benefit Trust	10,000,000	0
1.49506 %	Chelverton Asset Management Ltd.	6,166,666	0
1.46738 %	Callahan (Gerard)	6,052,509	0
1.16970 %	Hancock (Christopher Paul)	4,824,657	8,244
1.15055 %	Crofton (Kevin Timothy)	4,745,666	1,179,000
1.07704 %	Collantes (Luis)	4,442,485	4,442,485
0.96977 %	Herald Investment Management Limited	4,000,000	2,500,000
0.91279 %	Newlands (Monique)	3,765,000	1,430,000
0.82437 %	Craton (Jonathan)	3,400,294	0
0.76738 %	Sigaroudinia (Kave)	3,165,228	1,524,360
0.73618 %	Rees (Richard)	3,036,540	208,333
0.71935 %	Angel CoFund	2,967,120	0
0.66914 %	Toscafund Asset Management LLP	2,760,000	2,760,000
0.47555 %	Octopus Investments Limited	1,961,500	0
0.43672 %	Janus Henderson Investors	1,801,356	-454,000
0.40070 %	Gulliford (Craig Jonathan)	1,652,771	8,244
0.40003 %	Newlands (David John)	1,650,000	700,000
0.36366 %	Ronksley (Steve Patrick)	1,500,000	-127,471
0.36363 %	Edmondson (David Austin)	1,499,880	0
0.33241 %	Bradshaw (John)	1,371,082	0
0.24244 %	Hogg (Kathryn)	1,000,000	1,000,000
0.23201 %	Mc-Quade (Gerard)	956,975	0
0.22377 %	Crux Asset Management Limited	923,000	250,000
0.18375 %	Ede (Laurence John)	757,919	0
0.18183 %	Mc-Kenna (Jim)	750,004	-634,913
0.15686 %	Day (Steven Timothy)	647,010	0
0.15468 %	Palmer (Daniel)	638,010	0
0.14531 %	Avellemy Limited	599,375	0
0.13711 %	AFH Wealth Management	565,550	0
0.12139 %	Sargood (Graham Robert)	500,685	9,000
0.11156 %	Aspinwall (Christopher John Francis)	460,151	-562,500
0.10674 %	Woods (David)	440,255	0
0.10334 %	Donaldson (Kenneth Harry)	426,229	0
0.09819 %	Searle (Nicholas Peter)	405,000	320,000
0.09426 %	Perry (Ian)	388,800	0
0.08385 %	Mc-Lean (Hamish Donald Angus)	345,863	88,708
0.08351 %	Smith (Christopher)	344,442	88,751
0.07748 %	Kelly (Christopher Hugh)	319,602	-131,326
0.07708 %	Andrews (Phillip Stephen)	317,939	63,757
0.07661 %	Josson (Kashmir)	316,000	174,572
0.07647 %	Knight (Adam Digby)	315,409	0
0.07567 %	Craton (Caroline)	312,130	0
0.07480 %	Spicer (Charles Alexander Evan)	308,530	0
0.06948 %	Birnie (Jennifer Lucy)	286,564	0
0.06461 %	Evans (Georgina Ann)	266,497	0
0.06433 %	Crews (Rob)	265,347	0
0.05064 %	Amos (Peter)	208,877	0
0.04921 %	Sweetland (Philip)	202,964	0
0.04837 %	Millar (Ann)	199,496	-191,250
0.04364 %	Chisnall (Andrew)	180,000	32,392
0.03760 %	Goldsworthy (Simon Frank)	155,084	81,799
0.03727 %	Birnie (Andrew James)	153,726	0
0.03675 %	Smith (Anthony Julian)	151,593	13,305
0.03657 %	Schroder Investment Management North America Inc.	150,832	45,485
0.03509 %	Richardson (Gareth)	144,755	0
0.03387 %	Andrews (Sandra Ann)	139,699	37,721
0.03275 %	Jackson (Mark Bentley)	135,076	0
0.03031 %	Medellin (Ivonne Maria Gloria Cantu)	125,000	125,000
0.03031 %	Cantu (Ivonne Maria Gloria)	125,000	0
0.02822 %	Casimo (Antonino Filippo)	116,410	0
0.02822 %	Casimo (Julia Denise)	116,410	0
0.02518 %	Calder (Greg)	103,860	103,860
0.02424 %	Emes (Wendy)	100,000	100,000
0.02424 %	Emes (Jeffrey)	100,000	100,000
0.02424 %	Rees (Brenda)	100,000	100,000
0.02396 %	Chisnall (Kathryn)	98,821	10,256
0.02287 %	White (Malcolm)	94,320	0
0.02077 %	More (Stewart John Lamond)	85,651	0
0.02052 %	Craton (Timothy Charles)	84,620	0
0.01981 %	Bedborough (Amanda)	81,720	0
0.01909 %	James (Richard Paul)	78,741	0
0.01897 %	Singh (Davindar Kaur)	78,250	0
0.01891 %	Singh (Parminder)	78,000	0
0.01548 %	Wall (Pete)	63,840	0
0.01518 %	Russell Investments Limited	62,619	62,619
0.01424 %	Curtis (Stephen John)	58,745	0
0.01416 %	Chamberlain (Mark)	58,408	1,876
0.01392 %	Curtis (Alison)	57,419	0
0 %	Hamilton House Medical Ltd.	0	-779,096
0 %	Ebbutt (Aleksandra)	0	-54,748
0 %	Craton Hotchkin (Sherry)	0	-59,136
0 %	Ebbutt (Mark)	0	-96,976
0 %	Thomas (Susan)	0	-53,049
0 %	Rafferty (Ciaran)	0	-88,292
0 %	Hoult (Gary)	0	-110,000
0 %	Bishop (John)	0	-90,000
0 %	Evelyn Partners Investment Management LLP	0	-68,401
0 %	Fidelity International	0	-1,365,367
0 %	Buckland (Martin)	0	-53,877
0 %	Dharmasiri (Chalika Nuwan)	0	-54,000
0 %	Dowgate Wealth Limited	0	-375,000

이름	관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
M&G	공급업체고객	0,20	-0,12	-0,49	0,45	-0,01
Cenkos Securities	공급업체고객	0,50	-0,33	0,26	0,61	-0,02
Canaccord Genuity Group	공급업체고객	0,53	0,89	0,79	0,28	-0,18

What values and corporate philosophy does Creo Medical Group represent?

Creo Medical Group PLC represents values such as innovation, integrity, and excellence. The company is dedicated to delivering cutting-edge medical solutions to improve patient outcomes. Creo Medical Group PLC follows a patient-centric approach, ensuring that their products and technologies meet the highest standards of quality and effectiveness. Their corporate philosophy emphasizes the importance of collaboration, research, and development to provide advanced therapeutic solutions in the field of endoscopy and minimally invasive surgery. With a strong focus on continuous improvement and customer satisfaction, Creo Medical Group PLC strives to contribute to the advancement of medical technology for the benefit of patients worldwide.

In which countries and regions is Creo Medical Group primarily present?

Creo Medical Group PLC is primarily present in various countries and regions around the world. Some of the key markets where the company operates include the United Kingdom, Europe, Asia-Pacific, and North America. With its global presence, Creo Medical Group PLC caters to a wide range of customers and investors across different geographical locations.

What significant milestones has the company Creo Medical Group achieved?

Creo Medical Group PLC has achieved significant milestones since its establishment. Some noteworthy achievements include the FDA clearance for their Speedboat RS2 device, allowing the company to enter the US market and expand its customer base. Additionally, Creo Medical Group PLC received CE Mark approval for its CROMA platform, enabling commercialization in the European market. The company also secured key partnerships and collaborations with renowned medical institutions and professionals, highlighting its commitment to innovation and development in the medical device sector. With these milestones, Creo Medical Group PLC has established itself as a leading player in the field, dedicated to improving patient outcomes through advanced technology.

What is the history and background of the company Creo Medical Group?

Creo Medical Group PLC, a leading medical device company based in the UK, was founded in 2003. The company specializes in the development and commercialization of advanced surgical instruments. Creo Medical has a strong focus on non-invasive surgical technologies that provide effective treatments with minimal patient discomfort and enhanced recovery. With a talented team of professionals, Creo Medical has achieved significant milestones in its history, including the successful launch of its flagship device, the CROMA™ Advanced Energy Platform. The company is committed to driving innovation in the medical field, working towards improving patient outcomes and revolutionizing surgical procedures globally. Creo Medical Group PLC continues to grow and establish a strong presence in the market through its dedication to research, development, and commercialization of cutting-edge medical devices.

Who are the main competitors of Creo Medical Group in the market?

The main competitors of Creo Medical Group PLC in the market are (insert competitor names here).

In which industries is Creo Medical Group primarily active?

Creo Medical Group PLC is primarily active in the medical technology industry.

What is the business model of Creo Medical Group?

The business model of Creo Medical Group PLC revolves around developing and commercializing medical devices for surgical endoscopy. Creo Medical specializes in advanced energy devices and aims to provide innovative solutions for minimally invasive procedures, such as radiofrequency ablation and microwave coagulation. By leveraging its proprietary technology, Creo Medical aims to enable healthcare professionals to improve patient outcomes, minimize complications, and reduce healthcare costs. With a focus on enhancing clinical capabilities and expanding its product portfolio, Creo Medical Group PLC continues to drive innovation in the medical device industry.

Creo Medical Group 2025의 P/E 비율은 얼마입니까?

Creo Medical Group의 P/E 비율은 -3.54입니다.

Creo Medical Group 2025의 KUV는 얼마입니까?

Creo Medical Group의 P/S 비율은 2.67입니다.

Creo Medical Group의 AlleAktien 품질 점수는 얼마인가요?

Creo Medical Group에 대한 AlleAktien 품질 점수는 4/10입니다.

Creo Medical Group 2025의 매출은 얼마인가요?

예상되는 Creo Medical Group 매출은 16.28 백만 GBP입니다.

Creo Medical Group 2025의 이익은 얼마인가요?

예상되는 Creo Medical Group 이익은 -12.28 백만 GBP입니다.

Creo Medical Group은 무엇을 하나요?

Creo Medical Group PLC is a British medical technology company that specializes in the development and marketing of advanced medical technologies for endoscopy. The company was founded in 2003 and is headquartered in Chepstow, Wales.

Creo Medical Group 배당금은 얼마입니까?

Creo Medical Group은(는) 연간 번의 배당을 통해 0 GBP의 배당금을 지급합니다.

Creo Medical Group이 얼마나 자주 배당을 지급하나요?

Creo Medical Group의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Creo Medical Group ISIN이 무엇입니까?

Creo Medical Group의 ISIN은 GB00BZ1BLL44입니다.

Creo Medical Group WKN은 무엇인가요?

Creo Medical Group의 WKN은 A2DH40입니다.

Creo Medical Group 티커는 무엇인가요?

Creo Medical Group의 티커는 CREO.L입니다.

Creo Medical Group이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Creo Medical Group은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Creo Medical Group은(는) 0 GBP의 배당금을 지급할 것으로 예상됩니다.

Creo Medical Group의 배당 수익률은 얼마입니까?

Creo Medical Group의 현재 배당 수익률은 입니다.

Creo Medical Group의 배당금은 언제 지급되나요?

Creo Medical Group은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Creo Medical Group의 배당금은 얼마나 안전한가요?

Creo Medical Group은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

Creo Medical Group의 배당금은 얼마입니까?

향후 12개월 동안 0 GBP의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Creo Medical Group이(가) 속해 있는 섹터는 어디인가요?

Creo Medical Group은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Creo Medical Group kaufen, um die vorherige Dividende zu erhalten?

Creo Medical Group의 마지막 배당금을 0 GBP만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Creo Medical Group의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Creo Medical Group의 2024년도 배당금은 얼마였습니까?

2024년에 Creo Medical Group는 0 GBP를 배당금으로 지급했습니다.

Creo Medical Group는 어떤 화폐로 배당금을 지급하나요?

Creo Medical Group의 배당금은 GBP에 지급됩니다.

Creo Medical Group 티커	Creo Medical Group FIGI
CREO:LN	BBG00FF47ZS6
CREOGBX:EO	BBG00FHTGST4
CREOGBX:XH	BBG00FHTGSX9
CREOGBX:XF	BBG00FHTGSZ7
CREOGBX:XE	BBG00FHTGT12
CREOGBX:XJ	BBG00FHTGT21
CREOGBX:XL	BBG00FHTGT30
CREOGBX:XG	BBG00FHTGT49
CREOGBX:XO	BBG00FHTGT58
CREOGBX:XS	BBG00FHTGT94
CREOGBX:XA	BBG00FHTGTB1
CREOGBX:E1	BBG00FHTGTC0
CREOGBX:XT	BBG00FHTGTD9
CREOGBX:XW	BBG00FHTGTF7
CREOGBX:XU	BBG00FHTGTG6
CREOGBX:XV	BBG00FHTGTH5
CREOGBX:EU	BBG00FHTGTK1
CREOL:L3	BBG00FHXZWH8
CREOL:B3	BBG00FHY0084
CREOL:PO	BBG00FHY0477
1RC:GR	BBG00FJCHFJ7
1RC:GF	BBG00FJCHFK5
1RC:GS	BBG00FJCHFN2
CREO1EUR:EO	BBG00FJWD867
CREO1EUR:XH	BBG00FJWD894
CREO1EUR:XF	BBG00FJWD8C0
CREO1EUR:XE	BBG00FJWD8F7
CREO1EUR:XJ	BBG00FJWD8G6
CREO1EUR:XL	BBG00FJWD8H5
CREO1EUR:XG	BBG00FJWD8J3
CREO1EUR:XO	BBG00FJWD8K1
CREO1EUR:XS	BBG00FJWD8P6
CREO1EUR:XA	BBG00FJWD8Q5
CREO1EUR:E1	BBG00FJWD8R4
CREO1EUR:XT	BBG00FJWD8S3
CREO1EUR:XW	BBG00FJWD8T2
CREO1EUR:XU	BBG00FJWD8V9
CREO1EUR:XV	BBG00FJWD8W8
CREO1EUR:EU	BBG00FJWD8Y6
CREOGBX:XX	BBG00JN8KMQ6
CREO1EUR:XX	BBG00JN8KPG0

한 눈에 저평가된 주식을 인식하세요

가격

가격

티커CREO.L

ISINGB00BZ1BLL44

WKNA2DH40

Creo Medical Group 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Creo Medical Group 주가 이력

Creo Medical Group 주식 매출, EBIT, 이익 GB00BZ1BLL44 · A2DH40

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Creo Medical Group 매출, 이익 및 EBIT 역사

Creo Medical Group 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Creo Medical Group 주식 마진 GB00BZ1BLL44 · A2DH40

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Creo Medical Group 마진 역사

Creo Medical Group 주식 매출, EBIT, 주당 순이익 GB00BZ1BLL44 · A2DH40

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Creo Medical Group 매출, 이익 및 EBIT 주당 역사

Creo Medical Group 주식 및 주식 분석

한눈에 과소평가된 주식을 인식하세요.

Creo Medical Group Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Creo Medical Group 역사적인 P/E, EBIT 및 P/S에 따른 평가

한눈에 과소평가된 주식을 인식하세요.

Creo Medical Group 주식 수량 GB00BZ1BLL44 · A2DH40

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

한눈에 과소평가된 주식을 인식하세요.

Creo Medical Group 수익 예상

Creo Medical Group 수익 놀라움

Creo Medical Group 주식 주주 구조

Creo Medical Group 임원진 및 경영진

Mr. Craig Gulliford

Mr. David Woods

Prof. Christopher Hancock

Mr. Richard Rees

Mr. Charles Spicer

Mr. John Bradshaw

티커
CREO.L

ISIN
GB00BZ1BLL44

WKN
A2DH40